ArticleInternational journal of hematology2022

Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.

Mariko Tsuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.